Literature DB >> 17458883

CD4dimCD25bright Treg cell frequencies above a standardized gating threshold are similar in asthmatics and controls.

Hans Jürgen Hoffmann1, Tine M Malling, Ayfer Topcu, Lars P Ryder, Kaspar R Nielsen, Kim Varming, Ronald Dahl, Oyvind Omland, Torben Sigsgaard.   

Abstract

BACKGROUND: Thymus selected CD4(+)CD25(bright) natural regulatory Treg cells expressing FOXP3 may contribute to control of immune responses. No unique markers have been available to identify and characterize Treg. We present a gating strategy that allows enumeration of Treg on the basis of CD4 and CD25 and investigate whether asthmatics have fewer Treg than controls.
METHODS: Asthmatics and controls were selected from responses to a mailed questionnaire. CD25, CD4, HLA DR, and appropriate isotypes were recorded by flow cytometry.
RESULTS: The CD4 T cells expressing most CD25 are a separate population expressing FOXP3 and lower levels of CD4 and CD127. On a CD4 CD25 dot-plot, the CD4 MFI of Treg for 152 participants was calculated to be 0.83 +/- 0.043*MFI of CD25(bright) T-cells. CD4(dim)CD25(bright) T cells in a rectangular gate with a CD4 MFI </= 0.9 (0.83 + [2*0.043])*MFI of CD25(+) T cells were enumerated and shown to be similar for controls (median 8.34%) and asthmatics (median 10.1%). HLA DR expression on Treg correlated with CD25 expression.
CONCLUSIONS: A standardized two color gating method defines Treg. It may be applied in most clinical scenarios and is useful for sorting viable Treg. Asthmatics and controls have similar numbers of Treg.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17458883     DOI: 10.1002/cyto.a.20389

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  4 in total

1.  IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.

Authors:  Qiaoling Liang; Lei Guo; Shaila Gogate; Zunayet Karim; Arezoo Hanifi; Donald Y Leung; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  Effects of oral glucocorticoid therapy on CD4+CD25+CD127- and CD4+CD25high T cell levels in asthmatic patients.

Authors:  Marcin Moniuszko; Anna Bodzenta-Lukaszyk; Milena Dabrowska
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

3.  Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.

Authors:  Laure Vallotton; Karine Hadaya; Jean-Pierre Venetz; Leo H Buehler; Donatella Ciuffreda; Ghaleb Nseir; Laura Codarri; Jean Villard; Giuseppe Pantaleo; Manuel Pascual
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-14       Impact factor: 8.237

4.  Increased circulating regulatory T cells (CD4(+)CD25 (+)CD127 (-)) contribute to lymphocyte anergy in septic shock patients.

Authors:  Fabienne Venet; Chun-Shiang Chung; Hakim Kherouf; Anne Geeraert; Chistophe Malcus; Françoise Poitevin; Julien Bohé; Alain Lepape; Alfred Ayala; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2008-10-23       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.